1. Home
  2. SPOK vs CADL Comparison

SPOK vs CADL Comparison

Compare SPOK & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

HOLD

Current Price

$13.03

Market Cap

268.2M

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.08

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
CADL
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.2M
339.8M
IPO Year
1992
2021

Fundamental Metrics

Financial Performance
Metric
SPOK
CADL
Price
$13.03
$6.08
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.43
AVG Volume (30 Days)
170.7K
1.0M
Earning Date
10-29-2025
11-13-2025
Dividend Yield
9.67%
N/A
EPS Growth
12.68
N/A
EPS
0.80
N/A
Revenue
$139,739,000.00
N/A
Revenue This Year
$4.11
N/A
Revenue Next Year
$2.63
N/A
P/E Ratio
$16.16
N/A
Revenue Growth
1.47
N/A
52 Week Low
$12.26
$4.25
52 Week High
$19.31
$13.68

Technical Indicators

Market Signals
Indicator
SPOK
CADL
Relative Strength Index (RSI) 42.02 62.01
Support Level $12.83 $5.45
Resistance Level $13.69 $6.14
Average True Range (ATR) 0.26 0.42
MACD 0.05 0.04
Stochastic Oscillator 23.26 54.43

Price Performance

Historical Comparison
SPOK
CADL

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: